Increased bone marrow toxicity of doxorubicin bound to nanoparticles
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (6) , 820-826
- https://doi.org/10.1016/0959-8049(94)90299-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908International Journal of Pharmaceutics, 1993
- Nanoparticles as microcarriers for anticancer drugsAdvanced Drug Delivery Reviews, 1990
- Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticlesCancer Chemotherapy and Pharmacology, 1990
- Doxorubicin-Loaded Nanoparticles: Increased Efficiency in Murine Hepatic MetastasesSelective Cancer Therapeutics, 1989
- Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol‐rich liposomesFEBS Letters, 1988
- Degradation of poly (isobutyl cyanoacrylate) nanoparticlesBiomaterials, 1984
- Pharmacokinetics and distribution of a biodegradable drug-carrierInternational Journal of Pharmaceutics, 1983
- Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1982
- Tissue Distribution of Antitumor Drugs Associated with Polyalkylcyanoacrylate NanoparticlesJournal of Pharmaceutical Sciences, 1980
- Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive propertiesJournal of Pharmacy and Pharmacology, 1979